Quantum-Inspired Models Improve Pharmaceutical Marketing Predictions, Study Finds
A 2026 study published in the International Journal of Integrative Research shows that quantum-inspired decision models can significantly improve how pharmaceutical companies predict patient and physician behavior. The research was conducted by Rehan Haider from the Department of Pharmacy at the University of Karachi, Geetha Kumari Das from GD Pharmaceutical Inc at OPJS University in Rajasthan, and Hina Abbas from Dow University of Health Sciences Karachi. Their findings suggest that quantum-based models outperform traditional statistical tools in understanding complex healthcare decisions shaped by emotion, uncertainty, and digital influence.
The study, released in Volume 4, Issue 2 (2026), addresses a growing challenge in pharmaceutical marketing: patients and doctors do not always make rational, linear decisions. In an era dominated by digital platforms, artificial intelligence, and social media health content, treatment choices are increasingly influenced by emotional triggers, information overload, and virtual interactions. Traditional marketing analytics struggle to explain these shifting behaviors.
Why Classical Models Fall Short
For decades, pharmaceutical marketing relied on classical economic and behavioral theories. These models assume that individuals weigh risks and benefits logically before making decisions. However, real-world healthcare choices often involve hesitation, emotional conflict, and sudden preference changes.
Behavioral economics has shown that people are influenced by framing effects, loss aversion, and cognitive bias. In medical settings, patients may switch brands unexpectedly or delay treatment despite clear clinical benefits. Physicians may hesitate between prescribing alternatives based on contextual information or digital engagement.
According to Rehan Haider and his colleagues at the University of Karachi and Dow University of Health Sciences Karachi, these inconsistencies reflect deeper cognitive uncertainty that classical probability models cannot fully capture.
What Is Quantum Decision Theory?
Quantum Decision Theory (QDT) does not involve quantum physics in medicine. Instead, it borrows mathematical principles from quantum probability to describe how humans think under uncertainty.
Unlike traditional models that treat decisions as fixed and sequential, QDT allows multiple potential choices to exist simultaneously before a final decision is made. Emotional context, digital messaging, and new information can interfere with and reshape these potential states.
This framework is particularly relevant in digital pharmaceutical marketing, where patients and physicians are exposed to online advertisements, AI-generated content, social media influencers, and hybrid digital-clinical communication systems.
How the Study Was Conducted
The research team used a quantitative simulation design combined with theoretical modeling.
They analyzed simulated behavioral datasets representing:
-2,500 consumers (patients)
-750 physicians
The researchers compared four analytical approaches:
-Classical logistic regression
-Quantum-probabilistic interference models
-Contextual amplitude modeling
-Bayesian comparison metrics
They evaluated model performance using standard accuracy indicators, including predictive accuracy and error measurement tools.
The goal was to determine which approach better predicted:
-Patient adherence
-Physician prescribing behavior
-Brand switching tendencies
-Digital influence responses
-Hesitation states
Key Findings
Quantum-inspired models outperformed classical statistical models across multiple behavioral dimensions.
The study reports:
-32% improvement in predicting preference reversal
-21% improvement in modeling hesitation
-29% reduction in prediction error for digital influence responses
-Statistically significant contextual interference patterns (p < 0.01)
The quantum-based approach was particularly effective in capturing what the researchers describe as “decision superposition,” where individuals simultaneously consider multiple treatment options before settling on one.
The models also identified “interference effects,” where emotional or contextual factors strengthened or weakened final decisions. Digital-triggered emotional responses—referred to as “virtual affect”—were shown to generate nonlinear decision patterns that traditional models failed to anticipate.
Physician prescribing simulations demonstrated improved accuracy in forecasting hesitation and likelihood of switching brands when quantum-probabilistic methods were applied.
Real-World Implications
The findings have important implications for pharmaceutical companies, healthcare marketers, and policymakers.
First, segmentation and targeting strategies could become more precise. By recognizing that patients and physicians may hold overlapping or unstable preferences, companies can design communication strategies that address uncertainty rather than assume fixed choices.
Second, digital marketing optimization may improve. Since virtual affect plays a measurable role in shaping decisions, companies can better evaluate how online campaigns, influencer messaging, and AI-driven tools influence treatment adoption.
Third, ethical communication strategies can benefit from improved prediction accuracy. Understanding hesitation and emotional conflict may help pharmaceutical firms avoid manipulative messaging and instead support clearer, more responsible health communication.
Rehan Haider of the University of Karachi explains that quantum-inspired models “offer greater explanatory power in situations involving cognitive uncertainty, emotional conflict, and digital influence.” He emphasizes that pharmaceutical environments are increasingly information-heavy and emotionally charged, requiring more advanced analytical frameworks.
Hina Abbas from Dow University of Health Sciences Karachi adds that the integration of behavioral economics with quantum-probabilistic modeling helps create a more realistic representation of how healthcare decisions unfold in digital ecosystems.
Broader Impact on Healthcare Analytics
The study contributes to a growing body of research applying quantum-inspired methods to psychology, finance, and consumer science. However, its application to pharmaceutical marketing analytics fills a significant research gap.
By mathematically modeling hesitation, contextual interference, and emotional shifts, the framework provides a new way to forecast treatment adoption and brand engagement.
In a healthcare market shaped by AI-driven persuasion tools and hybrid digital-clinical ecosystems, this approach could redefine predictive analytics standards.
The researchers recommend further empirical testing using real-world clinical and marketing datasets to validate and refine the framework.
Author Profiles
Rehan Haider, Pharm.D.
Department of Pharmacy, University of Karachi, Pakistan.
Expertise: Pharmaceutical marketing analytics, behavioral modeling, healthcare decision science.
Geetha Kumari Das, Ph.D.
GD Pharmaceutical Inc, OPJS University, Rajasthan.
Expertise: Pharmaceutical strategy, digital influence, applied analytics.
Hina Abbas, Pharm.D.
Dow University of Health Sciences Karachi, Pakistan.
Expertise: Clinical pharmacy, prescribing behavior, healthcare systems research.
Source
Haider, R., Das, G.K., & Abbas, H. (2026). Quantum-Inspired Decision Models in Pharmaceutical Marketing Strategies. International Journal of Integrative Research, Vol. 4, No. 2, pp. 99–104.
DOI: https://doi.org/10.59890/ijir.v4i2.136
0 Komentar